Hayley Lewis

This profile gathers the share dealings of Hayley Lewis in Zosano Pharma Corp, where the filings describe the role as chief executive. In total, 4 filings cover trades dated from 19 August 2016 to 4 June 2021.

On the open market, the record shows 1 purchase worth €5,554 and 1 sale worth €1,134. On balance, insiders were net buyers of €4,420. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants. Since January 2021: no purchases and 1 sale on the market.

The record was last updated on 7 June 2021 with an open-market sale (€1,134) in Zosano Pharma Corp. The last insider purchase was made public on 22 August 2016, 3,714 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.